Stock Track | GE HealthCare Soars 5.18% Intraday on Strong Q4 Earnings Beat and Upbeat 2026 Guidance

Stock Track

Feb 04

GE HealthCare Technologies Inc.'s stock surged 5.18% during intraday trading on Wednesday, following the release of its fourth-quarter and full-year 2025 financial results.

The medical device maker reported quarterly revenue of $5.70 billion, beating analyst estimates of $5.61 billion and representing a 7.1% year-over-year increase. Adjusted earnings per share came in at $1.44, surpassing the consensus estimate of $1.40. The company attributed this performance to robust demand for its diagnostic and imaging devices, driven by resilient demand for medical procedures, particularly from older Americans, and strength in U.S. and European markets.

Furthermore, GE HealthCare provided an optimistic outlook for 2026, forecasting adjusted earnings per share in the range of $4.95 to $5.15, above analysts' expectations of $4.92. The company also expects organic revenue growth of 3% to 4% year-over-year. Additionally, management indicated that the anticipated tariff impact for 2026 is expected to be lower than in 2025 based on current rates, providing further positive sentiment for investors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1124961263"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1124961263\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1124961263?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-04 22:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124961263","market":"us","top_or_hot":-1,"title":"Stock Track | GE HealthCare Soars 5.18% Intraday on Strong Q4 Earnings Beat and Upbeat 2026 Guidance","media":"Stock Track","content":"<p>GE HealthCare Technologies Inc.'s stock surged 5.18% during intraday trading on Wednesday, following the release of its fourth-quarter and full-year 2025 financial results.</p><p>The medical device maker reported quarterly revenue of $5.70 billion, beating analyst estimates of $5.61 billion and representing a 7.1% year-over-year increase. Adjusted earnings per share came in at $1.44, surpassing the consensus estimate of $1.40. The company attributed this performance to robust demand for its diagnostic and imaging devices, driven by resilient demand for medical procedures, particularly from older Americans, and strength in U.S. and European markets.</p><p>Furthermore, GE HealthCare provided an optimistic outlook for 2026, forecasting adjusted earnings per share in the range of $4.95 to $5.15, above analysts' expectations of $4.92. The company also expects organic revenue growth of 3% to 4% year-over-year. Additionally, management indicated that the anticipated tariff impact for 2026 is expected to be lower than in 2025 based on current rates, providing further positive sentiment for investors.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | GE HealthCare Soars 5.18% Intraday on Strong Q4 Earnings Beat and Upbeat 2026 Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | GE HealthCare Soars 5.18% Intraday on Strong Q4 Earnings Beat and Upbeat 2026 Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-04 22:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GE HealthCare Technologies Inc.'s stock surged 5.18% during intraday trading on Wednesday, following the release of its fourth-quarter and full-year 2025 financial results.</p><p>The medical device maker reported quarterly revenue of $5.70 billion, beating analyst estimates of $5.61 billion and representing a 7.1% year-over-year increase. Adjusted earnings per share came in at $1.44, surpassing the consensus estimate of $1.40. The company attributed this performance to robust demand for its diagnostic and imaging devices, driven by resilient demand for medical procedures, particularly from older Americans, and strength in U.S. and European markets.</p><p>Furthermore, GE HealthCare provided an optimistic outlook for 2026, forecasting adjusted earnings per share in the range of $4.95 to $5.15, above analysts' expectations of $4.92. The company also expects organic revenue growth of 3% to 4% year-over-year. Additionally, management indicated that the anticipated tariff impact for 2026 is expected to be lower than in 2025 based on current rates, providing further positive sentiment for investors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GEHC","symbol_name":"GE HEALTHCARE TECHNOLOGIES INC","start_time":0,"source_url":"","article_id":"1124961263","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124961263","pubTimestamp":1770217035,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"GE HealthCare Technologies Inc.'s stock surged 5.18% during intraday trading on Wednesday, following the release of its fourth-quarter and full-year 2025 financial results.The medical device maker...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GEHC":"GE HEALTHCARE TECHNOLOGIES INC"},"translate_title":"股票追踪|GE HealthCare盘中飙升5.18%，因强劲的第四季度盈利和乐观的2026年指引","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GEHC":1},"content_text":"GE HealthCare Technologies Inc.'s stock surged 5.18% during intraday trading on Wednesday, following the release of its fourth-quarter and full-year 2025 financial results.The medical device maker reported quarterly revenue of $5.70 billion, beating analyst estimates of $5.61 billion and representing a 7.1% year-over-year increase. Adjusted earnings per share came in at $1.44, surpassing the consensus estimate of $1.40. The company attributed this performance to robust demand for its diagnostic and imaging devices, driven by resilient demand for medical procedures, particularly from older Americans, and strength in U.S. and European markets.Furthermore, GE HealthCare provided an optimistic outlook for 2026, forecasting adjusted earnings per share in the range of $4.95 to $5.15, above analysts' expectations of $4.92. The company also expects organic revenue growth of 3% to 4% year-over-year. Additionally, management indicated that the anticipated tariff impact for 2026 is expected to be lower than in 2025 based on current rates, providing further positive sentiment for investors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}